The Devil Is in the Details: Use, Limitations, and Implementation of Continuous Glucose Monitoring in the Inpatient Setting
Rebecca Longo, Renu Joshi
Abstract
Until recently, continuous glucose monitoring (CGM) systems were reserved for use in the outpatient setting or for investigational purposes in hospitalized patients. However, during the coronavirus disease 2019 pandemic, use of CGM in the inpatient setting has grown rapidly. This review outlines important details related to the accuracy, limitations, and implementation of, as well as necessary staff education for, inpatient CGM use and offers a glimpse into the future of CGM in the inpatient setting.
Topics & Concepts
MedicineContinuous glucose monitoringCoronavirus disease 2019 (COVID-19)PandemicIntensive care medicineInpatient care2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEMedical emergencyEmergency medicineDiseaseDiabetes mellitusHealth careInternal medicineInfectious disease (medical specialty)PathologyLawEconomic growthEndocrinologyGlycemicPolitical scienceOutbreakEconomicsDiabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disorders